Pharsight

Ionsys is owned by The Medicines Co.

Ionsys contains Fentanyl Hydrochloride.

Ionsys has a total of 9 drug patents out of which 1 drug patent has expired.

Expired drug patents of Ionsys are:

Ionsys was authorised for market use on 22 May, 2006.

Ionsys is available in system;iontophoresis, transdermal dosage forms.

Ionsys can be used as method for iontophoretic transdermal delivery of fentanyl hydrochloride.

The generics of Ionsys are possible to be released after 03 February, 2033.

Patent Number	Company	Patent Title	Patent Expiry
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6881208	THE MEDICINES CO	Method and device for transdermal electrotransport delivery of fentanyl and sufentanil	Apr, 2022 (9 months ago)
US6975902	THE MEDICINES CO	Reservoir and a series of related reservoirs for use in an electrotransport drug delivery device and devices comprised thereof	Apr, 2024 (1 year, 1 month from now)
US8301238	THE MEDICINES CO	Two-part electrotransport device	Sep, 2031 (8 years from now)
US9364656	THE MEDICINES CO	Method of storing an electrotransport drug delivery device	Sep, 2031 (8 years from now)
US9731121	THE MEDICINES CO	Switch validation circuit and method	Oct, 2031 (8 years from now)
US8781571	THE MEDICINES CO	Switch validation circuit and method	Mar, 2032 (9 years from now)
US8428708	THE MEDICINES CO	Self-test for analgesic product	May, 2032 (9 years from now)
US8428709	THE MEDICINES CO	Current control for electrotransport drug delivery	Jun, 2032 (9 years from now)
US9095706	THE MEDICINES CO	Self-test for analgesic product	Feb, 2033 (9 years from now)